Detalhe da pesquisa
1.
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants.
NPJ Vaccines
; 9(1): 41, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383584